FDA suspends clinical development of obesity drug after second US trial death
The US FDA has placed Zafgen’s obesity drug candidate on clinical hold after a second patient died during a Phase III trial.
Archives for December 3, 2015
GSK Japan delays alopecia drug launch after Catalent manufacturing halt
GSK has delayed the Japanese launch of a male pattern baldness drug after a production halt at a French facility operated by its CMO, Catalent.
IDT ups SE Asian oligonucleotide offering through AITbiotech deal
Increasing interest in human genome sequencing and editing is driving demand for oligonucleotides, says Integrated DNA Technologies (IDT) which is buying AITbiotech’s synthesis business in Singapore.
Russia investing to be next big market player in early-phase clinical research
Eager participants and shorter enrollments periods are among many reasons Russia is attracting more early-phase clinical trials says expert.
Parexel launches new clinical trial management system
Parexel says pharmaceutical companies could start managing their clinical trials in as little as four weeks with new system.
Therapure launches IPO to grow biologics contracting business
Therapure Biopharma Inc. plans to go public to fund the expansion of its manufacturing facility and CMO business.